|Articles|December 10, 2009

Negative Pressure Wound Devices Draw FDA Notice, Advice

The Food and Drug Administration (FDA) has notified health professionals, and advised patients, about rare but serious complications -- including deaths -- from the use of negative pressure wound therapy (NPWT).

Negative pressure wound therapy devices can help in the healing and closure of wounds. They create negative pressure (a vacuum) at well-sealed wound sites that can help remove fluids and infectious materials and draws wound edges together.

In a notification to health professionals and advice for patients issued on Nov. 13, 2009, FDA alerted that serious complications, especially bleeding and infection, have been reported in some patients using NPWT devices. To read the full FDA Consumer Update article, see Negative Pressure Wound Devices Draw FDA Notice, Advice, at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm193277.htm.


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.